BioSig (BSGM): Market Cap to Revenue

Symbol and logo of brand BioSig Technologies Inc. (BSGM)

Biosig Technologies (BSGM) is implementing high-precision signal filtering systems for cardiac surgery, enhancing the accuracy of heart imaging. The market cap-to-revenue ratio on GURU.Markets captures price dynamics, where the 18672.60 metric confirms the current level. Revenues are based on the sale of PUREEP complexes for data purification during ablations. Patent protection of the IT platform establishes the foundation for a competitive advantage, despite modest expansion rates across US clinics.

BSGM BioSig Technologies Inc. P/S Multiple (07/04/2022 - 09/12/2025)

Analytical breakdowns for BioSig (BSGM)

- stock exchange capitalization data:
General company analysis:BSGM biosig.com
Core merchandise of Biosig Technologies

Biosig Technologies focuses on the design of electrophysiological equipment while outsourcing production to minimize capital expenditures, making revenue the primary value driver. The current market cap-to-revenue ratio of 18672.60 reflects the relationship between the company's market value and its annual turnover, allowing investors to assess the premium paid for the asset and identify price anomalies before the publication of financial reports.

Competitors of Biosig Technologies

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|XAIR: P/S Multiple|PFSA (profusa.com) - Price-to-Revenue Ratio|SSKN (STRATA Skin Sciences Inc.) - P/S Multiple|glucotrack.com (GCTK) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio NanoVibronix (NAOV)|VERO - Price to Sales|Price-to-Revenue Ratio Nuwellis, Inc. NUWE|Price-to-Revenue Coefficient aethlonmedical.com (AEMD)|TransEnterix - P/S Multiple|Price-to-Revenue Coefficient Avinger Inc. AVGR|CUTR: P/S Multiple|Price-to-Revenue Multiple Know Labs Corporation KNW|Market Cap to Revenue NARI|NVRO: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RSLS (ReShape Lifesciences)|Market Cap to Sales Volume SILK